BioOne Corporation engages in the development, manufacturing, import, export, and supply of medical devices and equipment. It offers INTERCEPT Blood System, a single pathogen inactivation system for platelets and plasma, and pathogens and lymphocytes in blood products. The company also provides consulting services. BioOne Corporation was founded in 2003 and is based in Tokyo, Japan with subsidiary locations in China and Singapor
